Progenics collabs with VA on AI research for prostate cancer treatment
advertisement

Progenics collabs with VA on AI research for prostate cancer treatment

by John R. Fischer, Staff Reporter | July 30, 2019
Artificial Intelligence CT Molecular Imaging X-Ray

The VAGLAHS would prospectively validate algorithms for effective health management, with all image and associated clinical data anonymized before being processed by them, for data protection. Progenics’ AI platform handles all data encrypted in transit and at rest, and is designed in accordance with cybersecurity guidance, the NIST cybersecurity framework, and the Open Web Application Security Project (OWASP).

"The underlining technology is developed to be inherently agnostic of imaging modality and has the potential to be evaluated in any anatomical and/or functional imaging," said Anand. "The collaboration initially would focus on bone scan, which is the most ubiquitous imaging modality in metastatic prostate cancer, and PSMA-PyL PET/CT, which is revolutionizing the treatment management of patients with prostate cancer. However, the collaboration is open for all imaging modalities — PET, SPECT, CT, MR and Bone Scans."

Servicing GE, Philips and Siemens CT equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.


The Veterans Health Administration is the largest integrated healthcare system in America and provides care to nine million enrolled Veterans annually at 1,240 healthcare facilities. This includes 170 medical centers and 1,061 outpatient sites of care of varying complexity (VHA outpatient clinics).

Progenics hopes to evaluate the outcomes of the collaboration with VAGLAHS early next year and eventually open discussions for rolling out the program nationwide.

Back to HCB News

You Must Be Logged In To Post A Comment